Overview

Fluvastatin AmelIorates aTHerosclerosis Study

Status:
Unknown status

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The study is designed to assess the effect of statin on atherosclesrosis progression as well as to explore its potential mechanism besides lipid modifying , such as effect on inflammation and vascular calcification.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Anzhen Hospital

Collaborator:

Novartis

Treatments:

Fluvastatin